Infection and thyroid autoimmunity: A seroepidemiologic study of TPOaAb

Autoimmunity

Volumn 42, Issue 5, 2009, Pages 439-446

  Wasserman, Ellen E ^a   Nelson, Kenrad ^a   Rose, Noel R ^b   Rhode, Charles ^a   Pillion, Joseph P ^c   Seaberg, Eric ^a   Talor, Monica V ^b   Burek, Lynne ^b   Eaton, William ^a   Duggan, Anne ^a,b   Yolken, Robert H ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Seroepidemiology; T. gondii; Thyroiditis; Thyroperoxidase

Indexed keywords

IMMUNOGLOBULIN G; THYROID PEROXIDASE ANTIBODY;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION; PREGNANCY; SEROEPIDEMIOLOGY; SERUM; THYROID GLAND; TOXOPLASMA GONDII;

AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IODIDE PEROXIDASE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SEROEPIDEMIOLOGIC STUDIES; THYROIDITIS, AUTOIMMUNE; TOXOPLASMA; TOXOPLASMOSIS;

EID: 70749110988     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902787716     Document Type: Article

References (67)

1. Schoenfeld Y, Rose NR, editors. Infection and autoimmunity. Amsterdam: Elsevier; 2005.
2. Christen U, von Herrath MG. Infections and autoimmunity- Good or bad? J Immunol 2005;174:7481-7486.
3. Rose NR, Rasooly L, Saboori AM, et al. Linking iodine with autoimmune thyroiditis. Environ Health Perspect 1999; 107(Suppl. 5):749-752.
4. Gartner R, Gasnier BC, Dietrick JW, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002;87:1687-1691.
5. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004;150: 605-618.
6. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocrine Rev 1993;14(1):107-120.
7. Lehmann HW, Lutterbüse N, Plentz A, et al. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol 2008;21(3):379-383.
8. Sterzl I, Hrda P, Matucha P. Anti-helicobacter pylori, antithyroid peroxidase, anti-thyroglobulinand anti-gastric parietal cells antibodies in Czech population. Physiol Res 2008;57(s1): S135-S141.
9. Strieder TGA, Wenzel BE, Prummel MF, et al. Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease. Clin Exp Immunol 2003;132:278-282.
10. Zöphel K, Saller B, Wunderlich G, Grüning T, Koch R, Wilde J, Mann K, Franke WG. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: Implications for the definition of TPOAb reference intervals. Clin Lab 2003;49(11-12):591-600.
11. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol (Oxf) 1977;7:481-493.
12. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: A twentyyear follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
13. Wasserman EE, Nelson K, Rose NR, Eaton W, Pillion JP, Seaberg E, Talor MV, Burek L, Duggan A, Yolken RH. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: An epidemiologic assessment. Am J Epidem 2007;167(4):701-710.
14. Pinard JA, Leslie NS, Irvine PJ. Maternal serologic screening for toxoplasmosis. J Midwifery Women's Health 2003;48(5): 308-315.
15. Gras L, Gilbert RE, Wallon M, Peyron F, Corina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004;132: 541-548.
16. Petersen E. Toxoplasmosis. Fetal Neonat Med 2007;12: 214-223.
17. Eskild A, Bruu AL, Stray-Pedersen B, Jenum P. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. BJOG 2005;112:1620-1624.
18. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA. BMJ 2006; doi: 10.1136/bmj.38668. 616808.3A.
19. Avgil M, Ornoy A. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: Consequences of neonatal or intrauterine infection. Repro Toxicol 2006;21:436-445.
20. Svahn A, Berggren J, Parke A, Storsaeter J, et al. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol 2006;37(2):118-123.
21. Crowcroft NS, Vyse A, Brown DWG, Strachan DP. Epidemiology of Epstein-Barr virus infection in preadolescent children: Application of a new salivary method in Edinburgh, Scotland. J Epidemiol Commun Health 1998; 52:101-104.
22. Hollier LM, Grissom H. Human herpes viruses in pregnancy: Cytomegalovirus, Epstein-Barr virus, and Vaicella zoster virus. Clin Perinatol 2005;32:671-696.
23. Xu F, Schillinger JA, Sternberg AR, Johnson RE, Lee FK, Nahmias AJ, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and 2 in the United States, 1988-1994. J Infect Dis 2002;185:1019-1024.
24. National Center for Immunization and Respiratory Diseases. Annual Report Centers for Disease Control and Prevention, NIH 2008.
25. Lopez A, Dietz VJ, Wilson F, Navin TR, Jones JL. Preventing congenital toxoplasmosis. CDC recommendations regarding selected conditions affecting women's health. MMWR 2000;49(RQ-2RR-2):57-74, available at www.cdc.gov/mmwr/ preview/mmwrhtml/rr4902a5.htm.
26. Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Phys 2003;67:2131-2138, 2145-2146.
27. Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii infection in the United States, 1999-2000. EID 2003;9(11): 1371-1374.
28. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii in the United States: Seroprevalence and risk factors. AJE 2001;154(4):357-365.
29. Beazley DM, Egerman RS. Toxoplasmosis. Semin Perinatol 1998;22(4):332-338.
30. Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. AmJ Med 2005;118:212-216.
31. Kaul R, Chen P, Binder SR. Detection of Immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections. J Clin Microbiol 2004;42(12):5705-5709.
32. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M. The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune diseases-2008. IMAJ 2008;10: 8-12. (Pubitemid 351649455)
33. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital M. The mosaic of autoimmunity: Genetic factors involved in autoimmune diseases. IMAJ 2008;10:3-7.
34. Barzilai O, Sherer Y, Ram M, et al. Epstein-Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notoriouš A preliminary report. Ann NYAcad Sci 2007;1108: 567-577.
35. Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis 2006;64(1-2): 45-50.
36. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein- Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100:3019-3026.
37. Ascherio A, Munger K. Epidemiology of multiple sclerosis: From risk factors to prevention. Semin Neurol 2008; 28: 17-28. (Pubitemid 351273081)
38. Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y. The curiously sustpicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 2008;30:37-41.
39. Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000;11:220-224.
40. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms inmultiple sclerosis. JAMA 2005;293:2496-2500.
41. James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 2006; 18:462-467.
42. Buka SL, Tsuang MT, Torrey EF, et al. Maternal infections and subsequent psychosis among offspring. Arch Gen Psych 2001;58:1032-1037.
43. LaBenz PJ, LaBenz ES, editors. Early correlates of speech, language, and hearing. Littleton, MA: PSG Publishing Co. 1980.
44. Hardy JB, Shapiro S, Pathways to adulthood: A threegeneration urban study, 1960-1994: [Baltimore, Maryland]. Baltimore, MD: Johns Hopkins University, Department of Health Policy and Management [producers], 1998. Ann Arbor, MI: Interuniversity Consortium for Political and Social Research [distributor], 1999. Available at http://www.niehs.nih.gov/ research/atniehs/ labs/epi/studies/dde/docs/cb2420tg-app.pdf.
45. Lawlor JP, Gladen E, Dhavale D, et al. Modernization and enhancement of the Collaborative Perinatal Project. (195974 at ftp://sph-ftp.jhsph.edu (subdirectoryncpp)). (Funded by the Stanley Medical Research Institute, Bethesda, MD, and National Institute of Mental Health Grant 070333) Baltimore, MD: The Johns Hopkins University; 2005.
46. QUANTA Litee. TPO for in vitro diagnostic use (Laboratory reference manual). San Diego, CA: INOVA Diagnostics, Inc. 2003.
47. Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-Thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986;9(4):299-305.
48. Karges B, Muche R, Knerr I, Ertelt W, Wiesel T, et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: A randomized, controlled trial. J Clin Endocrinol Metab 2007;92:1647-1652.
49. Radon K, Dressel H, Windstetter D, Reichert J, Schmid M, Nowak D. Toxoplasma gondii infection, atopy and autoimmune disease. Eur J Med Res 2003;8:147-153.
50. Bach JF. The effect of infectionson susceptibility to autoimmune an allergic diseases. N Engl J Med 2002;347: 911-920.
51. Bach JF. Infections and autoimmune diseases. J Autoimmun 2005;25:74-80.
52. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, OldstoneMBA. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006;12(11):1301-1309.
53. Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y, Shoenfeld Y. Infections and autoimmune thyroid diseases: Parallel detection of antibodies against pathogens with proteomic technology. Autoimmunity Rev 2008;8:112-115.
54. Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000;10:871-887. (Pubitemid 30832604)
55. GlinoerD. Thyroid regulation and dysfunction in the pregnant patient. Chapter 14. Thyroid disease manager. Abbott Park, IL: Abbott Laboratories. Available at www.thyroidmanager. org/thyroidbook.htm (last updated April 4, 2006).
56. Smyth PPA, Wijeyaratne CN, Kaluarachi WN, . Sequential studies on thyroid antibodies during pregnancy. Thyroid 2005; 15:474-477.
57. Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity 2005;38(3):247-255.
58. Amital H, Gershwin ME, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum 2006;35(6): 341-343.
59. Zandman-Goddarda G, Shoenfeld Y. Infections and autoimmunity. Autoimmunity 2005;38(7):473-485.
60. Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity 2006;39(1):71-77.
61. Stahl W, Kaneda Y. Impaired thyroid function in murine toxoplasmosis. Parasitology 1998;117(3):217-222.
62. Stahl W, Kaneda Y. Aetiology of thyroidal dysfunction in murine toxoplasmosis. Parasitology 1998;117(3):223-227.
63. Gazzinelli RT, Denkers EY. Protozoan encounters with tolllike receptor signaling pathways: Implications for host parasitism. Nat Rev Immunol 2006;6(12):895-906.
64. Yarovinsky F. Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol Lett 2008;119: 17-21.
65. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6(11):823-835.
66. Mackay IR, Leskovsek NV, Rose NR. Cell damage and autoimmunity: A critical appraisal. J Autoimmun 2008;30: 5-11.
67. Laliberté J, Carruthers VB. Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 2008;65: 1900-1915.